4.8 Article

Mergeomics 2.0: a web server for multi-omics data integration to elucidate disease networks and predict therapeutics

期刊

NUCLEIC ACIDS RESEARCH
卷 49, 期 W1, 页码 W375-W387

出版社

OXFORD UNIV PRESS
DOI: 10.1093/nar/gkab405

关键词

-

资金

  1. NIH R01 [NS117148, NS111378, DK117850, HL145708, HL147883, HD100298]
  2. American Heart Association
  3. UCLA QCBio Collaboratory Postdoc Fellowship
  4. National Institutes of Health [NS117148, NS111378, DK117850, HL145708, HL147883, HD100298]

向作者/读者索取更多资源

The Mergeomics web server is a versatile online tool for multi-omics data integration and analysis of disease-related biological pathways, featuring four main functions for correcting marker dependencies, detecting biological processes, examining data consistency, and identifying key regulatory factors.
The Mergeomics web server is a flexible online tool for multi-omics data integration to derive biological pathways, networks, and key drivers important to disease pathogenesis and is based on the open source Mergeomics R package. The web server takes summary statistics of multi-omics disease association studies (GWAS, EWAS, TWAS, PWAS, etc.) as input and features four functions: Marker Dependency Filtering (MDF) to correct for known dependency between omics markers, Marker Set Enrichment Analysis (MSEA) to detect disease relevant biological processes, Meta-MSEA to examine the consistency of biological processes informed by various omics datasets, and Key Driver Analysis (KDA) to identify essential regulators of disease-associated pathways and networks. The web server has been extensively updated and streamlined in version 2.0 including an overhauled user interface, improved tutorials and results interpretation for each analytical step, inclusion of numerous disease GWAS, functional genomics datasets, and molecular networks to allow for comprehensive omics integrations, increased functionality to decrease user workload, and increased flexibility to cater to user-specific needs. Finally, we have incorporated our newly developed drug repositioning pipeline PharmOmics for prediction of potential drugs targeting disease processes that were identified by Mergeomics.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据